PhenoTips  

Toronto,  ON 
Canada
http://phenotips.com

• Booth: 1250

PhenoTips is the leading software solution for medical genetics and rare disease research, complete with user-friendly tools that automate pedigree drawing and risk assessment, enable next-generation phenotyping, and provide life-saving diagnostic insights. PhenoTips digitizes more aspects of genomics with a single tool that improves data accuracy, introduces consistency and ease, and facilitates borderless collaboration. Challenging the status quo of genomics, PhenoTips seamlessly integrates with any EHR, laboratory information management system, variant prioritization tool, or matchmaking system to centralize data and streamline workflows.  PhenoTips' solutions support multiple hospitals across the United States, NHS Trusts, Canadian provincial health authorities, and groundbreaking rare disease projects such as the Undiagnosed Diseases Network and Children's Mercy Hospital's Genomic Answers for Kids.

 Press Releases

• PhenoTips Pledges 1% Equity to Support CORD, CHEO Foundation, and SickKids Foundation (Oct 07, 2022)

  Toronto, Ontario: PhenoTips, producer of the leading software solution for medical genetics, is proud to announce the pledge of 1% of their equity to the Upside Foundation of Canada in support of CHEO Foundation, SickKids Foundation, and the Canadian Organization for Rare Disorders (CORD).

  The Upside Foundation of Canada is a registered Canadian charity that makes embedding social responsibility into high-growth, early-stage companies simple and effective. As the Canadian partner of the Pledge 1% movement, The Upside Foundation has empowered over 350 Canadian startups to pledge 1% of their equity to a charity of their choice, which is converted to a cash donation upon a liquidity event, resulting in $2.9M donated to Canadian charities to date.

  Impressed by The Upside Foundation’s mission to embed philanthropy into company DNA, PhenoTips chose to join Upside’s community of impact-driven companies.

  “PhenoTips was founded to advance rare disease research and diagnosis,” said PhenoTips’ CEO Dr. Orion Buske. “In order to stay true to our roots as we grow, it’s important that we give back to our founding communities by embedding social commitment in a way that aligns with our expanding vision, and the most effective way to strengthen this commitment is through equity.”

  The decision to split the equity donation between the SickKids Foundation, the CHEO Foundation, and CORD was made in order to honour PhenoTips’ roots.

  PhenoTips’ founding team originated at SickKids, and the company itself arose from a collaborative project with SickKids. In addition, SickKids’ mission to improve outcomes for childhood cancers and diseases as well as their advocacy and leadership in the adoption of genomic medicine deeply resonated with PhenoTips’ own.

  CHEO has partnered with, and helped shape, PhenoTips since the company's origins. As global leaders in rare disease research and genomic medicine, CHEO has acted as a hub of national rare disease projects that PhenoTips has been proud to support, including Care4Rare, SOLVE-RD, and Genomics4RD.

  Finally, as the Canadian patient advocacy organization for rare disorders, CORD has been a strong supporter of PhenoTips’ work as well as an active leader in the efforts to improve the lives and reduce diagnostic odysseys of individuals living with rare diseases.

  “Ultimately, improving outcomes for patients with rare disease and inherited conditions has always been fundamental to why PhenoTips exists,” said PhenoTips’ COO and VP of Scientific & Medical Affairs Dr. Pawel Buczkowicz. “Today, with our pledge, we are further committing to support and give back to the community that inspired our very existence.”

  By pledging this donation to the SickKids Foundation, the CHEO Foundation, and CORD, PhenoTips is reinforcing the company’s core values by supporting the advancement of rare and genetic disorder research, as well as supporting the researchers and clinicians who are driving genomic medicine forward and expanding its application and availability to improve diagnosis and care.

  In light of PhenoTips’ pledge, the Upside Foundation stated: “We are pleased to welcome PhenoTips to the growing community of Canadian startups who are making meaningful commitments to corporate social responsibility by pledging donations of equity and sharing their success with their communities. Congratulations to the founders of PhenoTips for exemplifying their Upside pledge by supporting diverse charities during rare disease awareness month."

  With the recent closure of PhenoTips’ seed fundraising round, the company is experiencing rapid growth and expanding into health systems across Canada, the US, and the UK. Thanks to the Upside Foundation, PhenoTips’ trajectory indicates this pledge could have significant value in the future, with real world implications for the advancement of genomic medicine research as well as rare disease patient advocacy through the work CORD, the CHEO Foundation, and the SickKids Foundation do.

  About PhenoTips: PhenoTips is the leading software solution for medical genetics. Founded in 2014 out of a research project at The Hospital for Sick Children (SickKids) and the University of Toronto, PhenoTips’ software addresses the challenges commonly faced in medical genetics with a single solution, while preparing clinics for the proliferation of genetic testing into mainstream healthcare. PhenoTips’ solutions support multiple Canadian provincial health authorities, UK NHS Trusts, individual hospitals in four countries, and genetics industry leaders including Regeneron and Genome Medical. Learn more about PhenoTips at phenotips.com

  About The Upside Foundation of Canada: The Upside Foundation of Canada brings the Canadian tech and innovation community together to build social responsibility into their business in a way that is simple and effective. Founders of early-stage, high-growth companies are empowered to share their success with their communities by donating stock options or warrants, which, upon successful liquidity event, convert to a donation to the charity of their choice. Learn more about The Upside Foundation of Canada at upsidefoundation.ca

• PhenoTips Closes CAD $2.5M Funding Round Led by GreenSky Capital for Software to Transform Medical Genetics (Oct 07, 2022)

  Toronto, Canada, September 21, 2021 – Genetics software startup PhenoTips® announced today that it has raised CAD $2.5 million in an oversubscribed seed fundraising round led by the GreenSky Accelerator Fund IV. This round includes the support of the Toronto Innovation Acceleration Partners, Thin Air Labs, Yorkville Partners, and angel investors including members of the GreenSky President’s Club.

   

  PhenoTips empowers healthcare providers to deliver precision medicine with the most complete and interoperable software solution for medical genetics. PhenoTips’ technology is used by leading genetic care providers in four countries, across four NHS Trusts and two provincial Canadian health systems, currently serving over 200,000 patients with tools that enable deep phenotyping, family history, and genomic analysis. With the additional funds from this seed round, the company plans to double the size of its twelve-person Canada-based team and expand its cloud-based product offerings.

   

  “PhenoTips started eight years ago as an academic research project to help specialists record more standardized patient data at a nearby hospital’s genetics clinic,” said CEO, Dr. Orion Buske. “Today, we help specialists around the world not just record, but also use this information to help diagnose patients and advance genetics research. We are excited to be joined by a stellar group of prominent investors in the Canadian startup ecosystem, with deep expertise in digital health and enterprise software, to help us realize a future in which the responsible use of genetic data makes medicine more personalized and proactive. Their support will accelerate our efforts to empower the healthcare workers at the forefront of precision medicine.”

   

  "Today's financing announcement lays a strong foundation in support of PhenoTips' continued growth in the genomic healthcare market. We've been working diligently to push the field into the digital age, advancing the role of software and AI in medical genetics. This funding supports the future and long term vision of PhenoTips", said COO and VP of Scientific & Medical Affairs, Dr. Pawel Buczkowicz.

   

  In the last 20 years, the cost of sequencing a human genome has dropped from $10 million to under $1,000. This drop in cost, combined with the unique life-altering healthcare benefits attributed to sequencing, will see the genetic testing market reach an expected $28 billion by 2027. As the leading software provider for medical genetics, PhenoTips is uniquely positioned to capitalize on this growing market due to the PhenoTips software’s ability to unify genetic infrastructure across multiple disciplines, while providing seamless communication between systems regardless of their make or model.

   

  Said GreenSky Managing Partner, Greg Stewart: “PhenoTips works at the intersection of genetics and precision medicine - two areas that we believe are poised to experience outsized short and long-term growth. With a best-in-class product and a team composed of some of the key opinion leaders in the space, Phenotips is positioned to be a major player in the space.”

   

  First established as a SickKids and University of Toronto joint research project,  PhenoTips soon transitioned to clinical use due in part to the software’s intuitive user interface. Last year, the company was one of 21 companies to graduate from the Health stream of the Creative Destruction Lab (CDL), a startup accelerator for massively scalable companies. This is the company’s first equity financing, and will help position PhenoTips as the de-facto solution for genetics and genomics providers worldwide as they prepare to scale services to accommodate the integration of genetics into everyday care.

   

  About PhenoTips

  PhenoTips is the leading software solution for medical genetics. Founded in 2014 out of a research project at The Hospital for Sick Children and the University of Toronto, PhenoTips’ software addresses the challenges commonly faced in medical genetics with a single solution, while preparing clinics for the proliferation of genetic testing into mainstream healthcare. PhenoTips’ solutions support multiple Canadian provincial health authorities, UK NHS Trusts, individual hospitals in four countries, and genetics industry leaders including Regeneron and Genome Medical. Learn more about PhenoTips at phenotips.com

   

  About GreenSky Capital and the GreenSky President’s Club

  GreenSky Capital Inc. is an award-winning Toronto-based firm that makes investments in early-stage Canadian technology companies through its affiliated venture capital funds and through facilitating the GreenSky President’s Club, a FedDev-registered angel group. Our principals bring a combination of experience in technology, entrepreneurship, law and finance to high-growth potential companies and dedicated entrepreneurs. Learn more about GreenSky at greenskycapital.com

• PhenoTips® launches Pre-Visit Patient Questionnaires that automatically generate pedigrees using patient-entered data (Oct 07, 2022)

  Toronto, Ontario: PhenoTips, creator of the world’s first complete Genomic Health Record™, has launched a digital tool that automatically generates pedigrees from patient-entered information. Pre-Visit Patient Questionnaires are delivered virtually to patients, building pedigrees and patient records in advance of a patient’s initial consultation, which improves the appointment efficiency by over 50% due to the elimination of manual data entry.

   

  Burnout continues to be a pressing issue for the medical genetics community, and since the average genetic professional spends more than twice as much time on administrative and data-entry-related activities when compared to patient interactions, Pre-Visit Patient Questionnaires are designed to redirect time towards quality care. In addition to attentive care, a patient’s experience is further improved by relieving the pressure of having to come up with their medical and family history on the spot.

   

  “When the Pre-Visit Patient Questionnaire is sent to the patient beforehand, they have time to collect this information, reach out to the relevant family members, and sometimes even review their own medical records. Having time to process and collect that information before an in-clinic visit is very helpful, and that helps with the completeness and accuracy of the information that the clinician captures.” Says PhenoTips’ Senior Product Manager, Akshat Khanna.

   

  When used in combination with PhenoTips’ Cancer Risk Assessment tool, Pre-Visit Patient Questionnaires promote preventative care with automatically generated cancer risk scores that identify high-risk patients before their initial consultation.

   

  PhenoTips’ Chief Executive Officer, Orion Buske notes, “As genetic sequencing becomes common practice in medicine, genetic professionals are experiencing record levels of fatigue and burnout. We hope that by automating manual tasks with tools like our Pre-Visit Patient Questionnaires, genetic counselors and geneticists can focus on what really matters, their wellbeing as well as the wellbeing of their patients.”
   

  Pre-Visit Patient Questionnaires can act as a stand-alone tool, or integrate with a clinic’s EHR or EHR’s patient-facing portal, such as Epic’s MyChart or Cerner’s MyHealth. To learn more about Pre-Visit Patient Questionnaires visit phenotips.com/blog.

   

  About PhenoTips: PhenoTips challenges the status quo of medical care in genetics, working towards a future where genetic data is unified, rather than siloed, to empower life-saving care. Founded in 2014 out of a research project at SickKids Hospital and the University of Toronto, PhenoTips’ software is designed to solve the problems commonly faced in medical genetics, with a Genomic Health Record System that makes data standardized, interoperable, and usable. PhenoTips’ solutions are used in over 60 countries by leading hospitals and research institutions.

• World’s First Genomic Health Record™, PhenoTips®, Graduates From the Creative Destruction Lab (Oct 07, 2022)

  Toronto, Ontario: PhenoTips®, the first precision medicine software company to offer a complete genomic health record™ system, has announced their graduation from the 2019-2020 Health stream of the Creative Destruction Lab (CDL) program, a startup accelerator hosted by the University of Toronto’s Rotman School of Management.

  Developed out of necessity, PhenoTips’ self-titled flagship software has the unique ability to fully integrate into existing genetic workflows, supporting digital data collection for improved efficiency and insights. Having now completed the CDL, PhenoTips is one of 21 companies to graduate from the Health stream out of over 2,000 total applicants.

  “To say we’ve grown as a company would be an understatement,” says PhenoTips CEO Dr. Orion Buske. “Over the 9-month duration of the program, our team has nearly doubled in size, we’ve rebranded, we’ve launched a new website, as well as an accessible, web-hosted offering for small teams and individuals.”

  “The feedback and guidance we’ve received from our mentors has been invaluable,” says PhenoTips COO Dr. Pawel Buczkowicz. “But in addition, the CDL has given us the opportunity to connect with our existing clients and users to better understand their needs.”

  As graduates, PhenoTips intends to apply lessons learned and continue towards their projected growth, which is needed now more than ever. “Because of the COVID-19 pandemic, patient care is 60% virtual. In the next 12-18 months, genomics will be forced to adjust to foreign, digital workflows, and we are in a unique position to ease this transition. It’s important to continue scaling, as we have been, to accomplish our mission of empowering life-saving genomic care and breakthrough discoveries.”

  About PhenoTips: PhenoTips challenges the status quo of medical care in genetics, working towards a future where genetic data is unified, rather than siloed, to empower life-saving care. Founded in 2014 out of a research project at SickKids Hospital and the University of Toronto, PhenoTips’ software is designed to solve the problems commonly faced in medical genetics, with a genomic health record™ system that makes data standardized, interoperable, and usable. PhenoTips’ solutions are used in over 60 countries by leading hospitals and research institutions, such as Stanford Children’s Health and Great Ormond Street Hospital.

  About the Creative Destruction Lab: The Creative Destruction Lab (CDL) is a seed-stage program for massively scalable, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process with the goal of maximizing equity-value creation. The CDL is particularly suited to early-stage companies with links to university research labs. Launched in 2012 at the Rotman School of Management at the University of Toronto, the program has now expanded with locations in Atlanta, Calgary, Halifax, Montreal, Oxford, Paris and Vancouver. Companies that graduated from the Lab's first five cohorts between 2012 and 2017 have generated more than $2.5 billion (CAD) in aggregate equity value. CDL graduates include Aluna (San Francisco), Deep Genomics (Toronto), Coastal Genomics (Vancouver), Atomwise (San Francisco), Automat (Montreal), BenchSci (Toronto), Kyndi (Palo Alto), Kepler (Toronto), and Heuritech (Paris).

• Gene42 Rebrands As PhenoTips® in Preparation for Long-Term Growth (Oct 07, 2022)

  Toronto, Ontario: Gene42, a leading provider of precision medicine software for hospitals such as SickKids, Stanford Children’s Health, and Great Ormond Street, today announced the launch of its new brand identity as PhenoTips®. This rebranding marks a milestone for the company, accompanying a rapidly expanding client base and recent doubling of the team size.

  “Our new brand reflects our software tools and the value of our solutions — it’s simple, clean, and trusted,” says Dr. Orion Buske, CEO at PhenoTips. “We are proud of the growth we’ve experienced as Gene42, but as PhenoTips we can better accommodate our new clients as well as continue to provide for our long-time supporters.”

  PhenoTips is evolving as a must-have software tool that saves hospitals time and money by streamlining the collection of the patient’s symptoms and family history data into machine-readable formats. High-quality, structured patient data powers artificial intelligence to suggest conditions, analyze genomes, and provide better insights faster. To further reduce the data-capturing burden, PhenoTips mirrors genetics workflows and can be integrated directly into electronic health record systems. To date, over 5,000 specialists in more than 60 countries have adopted PhenoTips as a necessary part of their practice.

  To accompany the rebrand, PhenoTips has released a new website and web-hosted software tool, PhenoTips Cloud. PhenoTips Cloud allows you to begin capturing secure data instantly with all the core features of PhenoTips, plus additional features, automatic updates, and the ability to access from anywhere with an internet connection.

  “It's amazing how far PhenoTips has come in 6 years, growing out of a need for capturing family history, genetic information, and phenotype data in machine-learning friendly formats,” says Dr. Pawel Buczkowicz, Chief Operating Officer at PhenoTips. “This rebrand will allow us to embrace our potential for growth while we continue to do what we do best — provide digital solutions for genomics.”

  About PhenoTips: PhenoTips is a Toronto-based health software company that specializes in workflows for genomic medicine. Founded in 2014 out of a research project at SickKids Hospital and the University of Toronto, PhenoTips is growing quickly to meet the needs of a rapidly expanding client base. PhenoTips’ solutions are used in over 60 countries by leading hospitals and research institutions for deep clinical phenotyping, pedigree drawing, and gene discovery.

 Products